Payden & Rygel’s Cigna CI Stock Holding History

Payden & Rygel’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-29,000	Closed	-$7.98M	–	118
2025 Q4	$7.98M	Sell	29,000 -9,800	-25%	-$2.75M	0.55%	62
2025 Q3	$11.2M	Buy	38,800 +7,500	+24%	+$2.22M	0.93%	49
2025 Q2	$10.3M	Buy	+31,300	New	+$10.1M	0.86%	59

Other funds holding CI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Payden & Rygel's CI Position: Q1 2026 in Review

Payden & Rygel sold out of Cigna (CI) in Q1 2026, closing a stake of 29,000 shares — an estimated $7.98M sold.

Payden & Rygel first reported a position in CI in Q2 2025 and held it in 3 quarters. The position peaked at $11.2M in Q3 2025. 1,666 funds tracked by Wall St. Rank hold CI as of Q1 2026.

Payden & Rygel reported no remaining Cigna position as of Q1 2026 after selling out during the quarter.
Payden & Rygel sold 29,000 Cigna shares in Q1 2026, an estimated $7.98M.
Payden & Rygel first reported a position in Cigna in Q2 2025 and held it in 3 quarters.
Payden & Rygel's Cigna position peaked at $11.2M in Q3 2025.
1,666 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Payden & Rygel's 13F filing for Q1 2026, filed 12 May 2026.